# A US cost-minimization model comparing ravulizumab versus eculizumab for the treatment of atypical hemolytic uremic syndrome

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/a-us-cost-minimization-model-comparing-ravulizumab-versus-eculizumab-for-the/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Yan Wang,Karissa Johnston,Evan Popoff,Karl-Johan Myrén,Antoinette Cheung,Claudio Faria,Ioannis Tomazos |
| Citations | 34 |
| DOI | 10.1080/13696998.2020.1831519 |
| Fields | Biochemistry, Genetics and Molecular Biology,Immunology and Microbiology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W3090724433 |
| PMID | 33001704 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Antoinette Cheung](https://scholariq.org/researchers/antoinette-cheung/)

## Paper journal

- [Journal of Medical Economics](https://scholariq.org/journals/journal-of-medical-economics/)

## Paper primary topic

- [Complement system in diseases](https://scholariq.org/topics/complement-system-in-diseases/)

## Paper topics

- [Complement system in diseases](https://scholariq.org/topics/complement-system-in-diseases/)
- [Escherichia coli research studies](https://scholariq.org/topics/escherichia-coli-research-studies/)
- [Lysosomal Storage Disorders Research](https://scholariq.org/topics/lysosomal-storage-disorders-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.